| Primary |
| Product Used For Unknown Indication |
40.3% |
| Depression |
31.3% |
| Affective Disorder |
4.2% |
| Anxiolytic Therapy |
2.8% |
| Psychotic Disorder |
2.8% |
| Antidepressant Therapy |
2.1% |
| Anxiety |
2.1% |
| Hallucination |
2.1% |
| Insomnia |
2.1% |
| Schizophrenia |
2.1% |
| Hypertension |
1.4% |
| Progressive Multifocal Leukoencephalopathy |
1.4% |
| Drug Use For Unknown Indication |
0.7% |
| Agitation |
0.7% |
| Appetite Lost |
0.7% |
| Delusion |
0.7% |
| Depressive Symptom |
0.7% |
| Drug Dependence |
0.7% |
| Headache |
0.7% |
| Hiv Infection |
0.7% |
|
| Restless Legs Syndrome |
11.5% |
| Sopor |
9.6% |
| Toxicity To Various Agents |
9.6% |
| Suicidal Ideation |
7.7% |
| Withdrawal Syndrome |
7.7% |
| Completed Suicide |
5.8% |
| Serotonin Syndrome |
5.8% |
| Suicide Attempt |
5.8% |
| White Blood Cell Count Decreased |
5.8% |
| Hyponatraemia |
3.8% |
| Nightmare |
3.8% |
| Sedation |
3.8% |
| Urinary Tract Infection |
3.8% |
| Weight Decreased |
3.8% |
| Acquired Epidermolysis Bullosa |
1.9% |
| Apparent Life Threatening Event |
1.9% |
| Dyslipidaemia |
1.9% |
| Electrocardiogram Qt Prolonged |
1.9% |
| Haemorrhage Subcutaneous |
1.9% |
| Hallucination, Visual |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
61.4% |
| Depression |
13.4% |
| Major Depression |
5.0% |
| Drug Use For Unknown Indication |
4.0% |
| Suicide Attempt |
3.0% |
| Anxiety |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Hepatitis C |
1.5% |
| Back Pain |
1.0% |
| Bipolar Disorder |
1.0% |
| Dementia |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Fibromyalgia |
1.0% |
| Schizophrenia |
1.0% |
| Asthma |
0.5% |
| Depressed Mood |
0.5% |
| Drug Dependence |
0.5% |
| Dyslipidaemia |
0.5% |
| Extrapyramidal Disorder |
0.5% |
| Hypertonia |
0.5% |
|
| Toxicity To Various Agents |
35.4% |
| Drug Abuse |
6.3% |
| Restless Legs Syndrome |
6.3% |
| Somnolence |
6.3% |
| Major Depression |
4.2% |
| Paraesthesia |
4.2% |
| Psychomotor Hyperactivity |
4.2% |
| Respiratory Arrest |
4.2% |
| Suicidal Ideation |
4.2% |
| Urinary Tract Infection |
4.2% |
| Completed Suicide |
2.1% |
| Full Blood Count Abnormal |
2.1% |
| Haemorrhagic Disorder |
2.1% |
| Inappropriate Antidiuretic Hormone Secretion |
2.1% |
| Incoherent |
2.1% |
| Intentional Self-injury |
2.1% |
| Interstitial Lung Disease |
2.1% |
| Joint Contracture |
2.1% |
| Mydriasis |
2.1% |
| Oedema Peripheral |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.3% |
| Hypertension |
7.3% |
| Hepatitis C |
5.2% |
| Multiple Sclerosis |
5.2% |
| Plasma Cell Myeloma |
5.2% |
| Rheumatoid Arthritis |
5.2% |
| Chronic Myeloid Leukaemia |
4.2% |
| Depression |
4.2% |
| Hodgkin's Disease |
4.2% |
| Psychotic Disorder |
4.2% |
| Analgesic Therapy |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Major Depression |
3.1% |
| Affective Disorder |
2.1% |
| Anxiety |
2.1% |
| Bipolar I Disorder |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Deep Vein Thrombosis |
2.1% |
| Depression Psychotic |
2.1% |
|
| Vomiting |
11.1% |
| Sensation Of Heaviness |
6.7% |
| Swelling Face |
6.7% |
| Tachycardia |
6.7% |
| Dysarthria |
4.4% |
| Lung Disorder |
4.4% |
| Mouth Ulceration |
4.4% |
| Nausea |
4.4% |
| Panic Attack |
4.4% |
| Pericarditis |
4.4% |
| Rash |
4.4% |
| Rhabdomyolysis |
4.4% |
| Somnambulism |
4.4% |
| Subarachnoid Haemorrhage |
4.4% |
| Suspected Transmission Of An Infectious Agent Via Product |
4.4% |
| Therapeutic Response Decreased |
4.4% |
| Tremor |
4.4% |
| Vision Blurred |
4.4% |
| Weight Decreased |
4.4% |
| Ageusia |
2.2% |
|
